{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:16:12Z","timestamp":1790194572860,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2015.00004","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T12:07:31Z","timestamp":1421928451000},"source":"Crossref","is-referenced-by-count":24,"title":["Intravenous Immunoglobulin and Immunomodulation of B-Cell \u00e2\u20ac\u201c in vitro and in vivo Effects"],"prefix":"10.3389","volume":"6","author":[{"given":"Milica","family":"Mitrevski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Marrapodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Camponeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena Monica","family":"Cavaliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lazzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Todi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Visentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,1,22]]},"reference":[{"issue":"21","key":"B1","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"Gelfand","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"B2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"3","author":"Schwab","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"B3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.coi.2005.03.005","article-title":"The role of CD22 and other inhibitory co-receptors in B-cell activation","volume":"17","author":"Nitschke","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"5787","key":"B5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"issue":"6","key":"B6","doi-asserted-by":"publisher","first-page":"e21246","DOI":"10.1371\/journal.pone.0021246","article-title":"Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia","volume":"6","author":"Guhr","year":"2011","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fimmu.2011.00096","article-title":"Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22","volume":"2","author":"Jellusova","year":"2012","journal-title":"Front Immunol"},{"issue":"10","key":"B8","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1182\/blood-2009-12-261461","article-title":"IVIg modulates BCR-signaling through CD22 and promotes apoptosis in mature human B lymphocytes","volume":"116","author":"S\u00c3\u00a9\u00c3\u00aft\u00c3\u00a9","year":"2010","journal-title":"Blood"},{"issue":"12","key":"B9","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1002\/eji.201242710","article-title":"B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo","volume":"42","author":"Schwab","year":"2012","journal-title":"Eur J Immunol"},{"issue":"1","key":"B10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","article-title":"Fc\u00ce\u00b3 receptors: old friends review and new family members","volume":"24","author":"Nimmerjahn","year":"2006","journal-title":"Immunity"},{"issue":"6466","key":"B11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/368070a0","article-title":"A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling","volume":"368","author":"Muta","year":"1994","journal-title":"Nature"},{"issue":"46","key":"B12","doi-asserted-by":"publisher","first-page":"18772","DOI":"10.1073\/pnas.1111810108","article-title":"Fc\u00ce\u00b3 receptor IIB (Fc\u00ce\u00b3RIIB) maintains humoral tolerance in the human immune system in vivo","volume":"108","author":"Baerenwaldt","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"B13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/ni1440","article-title":"Fc\u00ce\u00b3RIIb controls bone marrow plasma cell persistence and apoptosis","volume":"8","author":"Xiang","year":"2007","journal-title":"Nat Immunol"},{"issue":"6","key":"B14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S1074-7613(00)80074-6","article-title":"SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis","volume":"10","author":"Pearse","year":"1999","journal-title":"Immunity"},{"issue":"5503","key":"B15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"issue":"7","key":"B16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/icb.2009.36","article-title":"Intravenous immunoglobulin up-regulates the expression of the inhibitory FccIIB receptor on B cells","volume":"87","author":"Nikolova","year":"2009","journal-title":"Immunol Cell Biol"},{"issue":"12","key":"B17","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1073\/pnas.0807319106","article-title":"Impaired inhibitory Fc\u00ce\u00b3 receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy","volume":"106","author":"Tackenberg","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"B18","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1007\/s10875-014-0019-2","article-title":"Natural autoantibodies to Fc\u00ce\u00b3 receptors in intravenous immunoglobulins","volume":"34","author":"Bouhlal","year":"2014","journal-title":"J Clin Immunol"},{"issue":"12","key":"B19","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.4049\/jimmunol.143.12.4104","article-title":"Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig","volume":"143","author":"Rossi","year":"1989","journal-title":"J Immunol"},{"issue":"10","key":"B20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"B21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","article-title":"The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders","volume":"127","author":"Ballow","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"B22","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1007\/s10875-012-9842-5","article-title":"The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade","volume":"33","author":"Svetlicky","year":"2013","journal-title":"J Clin Immunol"},{"issue":"1\u00e2\u20ac\u201c2","key":"B23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jneuroim.2007.11.020","article-title":"A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis","volume":"194","author":"Fuchs","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"12","key":"B24","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1002\/1529-0131(200012)43:122722::AID-ANR123.0.CO;2-N","article-title":"Restricted VH3 gene usage in phage-displayed Fab that are selected by intravenous immunoglobulin","volume":"43","author":"Osei","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"1","key":"B25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1006\/clim.2001.5004","article-title":"The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3-23 and 3-30\/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy","volume":"99","author":"Leucht","year":"2001","journal-title":"Clin Immunol"},{"issue":"1","key":"B26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.imlet.2009.03.012","article-title":"Spontaneous internalization of IVIg in activated B cells","volume":"124","author":"Proulx","year":"2009","journal-title":"Immunol Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.clim.2010.01.001","article-title":"Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg)","volume":"135","author":"Proulx","year":"2010","journal-title":"Clin Immunol"},{"issue":"8","key":"B28","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2002-06-1684","article-title":"Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG","volume":"101","author":"De Grandmont","year":"2003","journal-title":"Blood"},{"issue":"2","key":"B29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.autrev.2011.08.004","article-title":"B cells are resistant to immunomodulation by IVIg-educated dendritic cells","volume":"11","author":"Maddur","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"1","key":"B30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2249.2009.03996.x","article-title":"Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production","volume":"158","author":"Heidt","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"B31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","article-title":"Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus","volume":"25","author":"Christensen","year":"2006","journal-title":"Immunity"},{"issue":"9","key":"B32","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1002\/art.24760","article-title":"Regression of systemic lupus erythematosus after development of an acquired toll-like receptor signalling defect and antibody deficiency","volume":"60","author":"Visentini","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"B33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jaut.2011.05.014","article-title":"TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase","volume":"37","author":"S\u00c3\u00a9it\u00c3\u00a9","year":"2011","journal-title":"J Autoimmun"},{"issue":"1","key":"B34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10875-010-9469-3","article-title":"IVIg attenuates TLR-9 activation in B cells from SLE patients","volume":"31","author":"Kessel","year":"2011","journal-title":"J Clin Immunol"},{"issue":"11","key":"B35","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/intimm\/dxn090","article-title":"Immunomodulation of human B cells following treatment with intravenous immunoglobulins involves increased phosphorylation of extracellular signal-regulated kinases 1 and 2","volume":"20","author":"Dussault","year":"2008","journal-title":"Int Immunol"},{"issue":"7","key":"B36","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.161.7.3781","article-title":"Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway","volume":"161","author":"Prasad","year":"1998","journal-title":"J Immunol"},{"issue":"2","key":"B37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1034\/j.1600-6143.2003.00011.x","article-title":"Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells","volume":"3","author":"Toyoda","year":"2003","journal-title":"Am J Transplant"},{"issue":"1","key":"B38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaci.2013.08.042","article-title":"Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells","volume":"133","author":"S\u00c3\u00a9\u00c3\u00aft\u00c3\u00a9","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"B39","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nri2133","article-title":"B-cell anergy: from transgenic models to naturally occurring anergic B cells?","volume":"7","author":"Cambier","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"B40","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/ni924","article-title":"Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling","volume":"4","author":"Rui","year":"2003","journal-title":"Nat Immunol"},{"issue":"2","key":"B41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jaci.2014.03.017","article-title":"Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency","volume":"134","author":"Visentini","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"32","key":"B42","doi-asserted-by":"publisher","first-page":"13451","DOI":"10.1073\/pnas.0901984106","article-title":"Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells","volume":"106","author":"Rakhmanov","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"B43","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/eji.201040862","article-title":"Telomere-dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency","volume":"41","author":"Visentini","year":"2011","journal-title":"Eur J Immunol"},{"issue":"24","key":"B44","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21- human naive B cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood"},{"issue":"2\u00e2\u20ac\u201c3","key":"B45","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12026-014-8599-8","article-title":"Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells","volume":"60","author":"Mitrevski","year":"2014","journal-title":"Immunol Res"},{"issue":"1","key":"B46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jaut.2010.09.006","article-title":"Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies","volume":"36","author":"Bayry","year":"2011","journal-title":"J Autoimmun"},{"issue":"5","key":"B47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0167-5699(98)01252-3","article-title":"High-avidity autoantibodies to cytokines","volume":"19","author":"Bendtzen","year":"1998","journal-title":"Immunol Today"},{"issue":"3","key":"B48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/icb.2011.111","article-title":"BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus","volume":"90","author":"Vincent","year":"2011","journal-title":"Immunol Cell Biol"},{"issue":"1\u00e2\u20ac\u201c2","key":"B49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jneuroim.2008.05.010","article-title":"Serum BAFF expression in patients with myasthenia gravis","volume":"199","author":"Kim","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"8","key":"B50","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3899\/jrheum.130677","article-title":"Expression of B cell activating factor (BAFF) and BAFF binding receptors in rheumatoid arthritis","volume":"40","author":"Leandro","year":"2013","journal-title":"J Rheumatol"},{"issue":"3","key":"B51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10875-007-9082-2","article-title":"BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer","volume":"27","author":"Le Pottier","year":"2007","journal-title":"J Clin Immunol"},{"issue":"1\u00e2\u20ac\u201c2","key":"B52","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jneuroim.2013.01.001","article-title":"Intravenous immunoglobulin inhibits BAFF production in chronic inflammatory demyelinating polyneuropathy \u00e2\u20ac\u201c a new mechanism of action?","volume":"256","author":"Bick","year":"2013","journal-title":"J Neuroimmunol"},{"issue":"1\u00e2\u20ac\u201c2","key":"B53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jneuroim.2014.06.007","article-title":"IVIG regulates BAFF expression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"274","author":"Ritter","year":"2014","journal-title":"J Neuroimmunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T05:40:25Z","timestamp":1690868425000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2015.00004\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,22]]},"references-count":53,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2015.00004","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,22]]}}}